Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1991 1
2000 1
2004 1
2005 1
2006 2
2008 1
2009 1
2017 1
2018 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Dilated cardiomyopathy 1M"
Page 1
Comparison of Mesenchymal Stem Cell Efficacy in Ischemic Versus Nonischemic Dilated Cardiomyopathy.
Tompkins BA, Rieger AC, Florea V, Banerjee MN, Natsumeda M, Nigh ED, Landin AM, Rodriguez GM, Hatzistergos KE, Schulman IH, Hare JM. Tompkins BA, et al. J Am Heart Assoc. 2018 Jul 12;7(14):e008460. doi: 10.1161/JAHA.117.008460. J Am Heart Assoc. 2018. PMID: 30005555 Free PMC article.
BACKGROUND: Ischemic cardiomyopathy (ICM) and dilated cardiomyopathy (DCM) differ in histopathology and prognosis. ...METHODS AND RESULTS: We conducted a subanalysis of 3 single-center, randomized, and blinded clinical trials: (1) TAC-HFT (Transendocar …
BACKGROUND: Ischemic cardiomyopathy (ICM) and dilated cardiomyopathy (DCM) differ in histopathology and prognosis …
Immunoadsorption in dilated cardiomyopathy.
Dörffel WV, Wallukat G, Baumann G, Felix SB. Dörffel WV, et al. Ther Apher. 2000 Jun;4(3):235-8. doi: 10.1046/j.1526-0968.2000.00177.x. Ther Apher. 2000. PMID: 10910026 Clinical Trial.
The prognosis for patients suffering from advanced stages of dilated cardiomyopathy (DCM) is poor. ...
The prognosis for patients suffering from advanced stages of dilated cardiomyopathy (DCM) is poor. ...
Dilated cardiomyopathy in childhood: problems of diagnosis and long-term follow-up.
Schmaltz AA, Apitz J, Hort W. Schmaltz AA, et al. Eur Heart J. 1987 Feb;8(2):100-5. doi: 10.1093/oxfordjournals.eurheartj.a062236. Eur Heart J. 1987. PMID: 3569307
Clinical profile and course of 13 infants and children (median age 2 years, range 2 months to 17 years) with dilated cardiomyopathy are presented. ...The main complications were rhythm disturbances (23%) and thrombus formation (15%). We could not identify any …
Clinical profile and course of 13 infants and children (median age 2 years, range 2 months to 17 years) with dilated cardio …
Immunoadsorption in idiopathic dilated cardiomyopathy, a 3-year follow-up.
Dörffel WV, Wallukat G, Dörffel Y, Felix SB, Baumann G. Dörffel WV, et al. Int J Cardiol. 2004 Dec;97(3):529-34. doi: 10.1016/j.ijcard.2004.03.001. Int J Cardiol. 2004. PMID: 15561344
OBJECTIVE: Recent studies have shown that immunoadsorption (IA) leads to improvements in left ventricular function and in functional status in selected patients with idiopathic dilated cardiomyopathy (DCM) and circulating autoantibodiesautoantibod. ...CONCLUSION: Im …
OBJECTIVE: Recent studies have shown that immunoadsorption (IA) leads to improvements in left ventricular function and in functional status …
Immunoadsorption in dilated cardiomyopathy: 6-month results from a randomized study.
Staudt A, Hummel A, Ruppert J, Dörr M, Trimpert C, Birkenmeier K, Krieg T, Staudt Y, Felix SB. Staudt A, et al. Am Heart J. 2006 Oct;152(4):712.e1-6. doi: 10.1016/j.ahj.2006.06.027. Am Heart J. 2006. PMID: 16996843 Clinical Trial.
BACKGROUND: Various randomized studies evidenced that immunoadsorption (IA) repeated at monthly intervals induced acute and prolonged hemodynamic benefit in patients with severe heart failure due to dilated cardiomyopathy. Some findings indicate that the use of only …
BACKGROUND: Various randomized studies evidenced that immunoadsorption (IA) repeated at monthly intervals induced acute and prolonged hemody …
Proximal aortic stiffness is related to left ventricular function and exercise capacity in patients with dilated cardiomyopathy.
Patrianakos AP, Parthenakis FI, Karakitsos D, Nyktari E, Vardas PE. Patrianakos AP, et al. Eur J Echocardiogr. 2009 May;10(3):425-32. doi: 10.1093/ejechocard/jen304. Epub 2008 Nov 28. Eur J Echocardiogr. 2009. PMID: 19042942
METHODS AND RESULTS: We examined 60 patients (52.1 +/- 12, 8 years) with non-ischaemic dilated cardiomyopathy (NIDC), New York Heart Association II-III, in sinus rhythm, left ventricular ejection fraction 30.1 +/- 8.6%, and 44 normals. ...Patients with advanced left …
METHODS AND RESULTS: We examined 60 patients (52.1 +/- 12, 8 years) with non-ischaemic dilated cardiomyopathy (NIDC), New York …
Hemodynamic and neuroendocrine response to acute administration of the phosphodiesterase inhibitor BM14.478 in patients with congestive heart failure.
Rauch B, Zimmermann R, Kapp M, Haass M, Von Molitor S, Smolarz A, Neumann FJ, Kübler W, Dietz R, Tillmanns H. Rauch B, et al. Clin Cardiol. 1991 May;14(5):386-95. doi: 10.1002/clc.4960140506. Clin Cardiol. 1991. PMID: 2049889 Free article.
Hemodynamic parameters and plasma hormone levels of 8 patients (1 female, 7 male) with chronic congestive heart failure NYHA Classes II-IV (1 patient with coronary artery disease, 7 patients with primary dilated cardiomyopathy) were assessed before and until 6 h aft …
Hemodynamic parameters and plasma hormone levels of 8 patients (1 female, 7 male) with chronic congestive heart failure NYHA Classes II-IV ( …
Role of immunoglobulin G3 subclass in dilated cardiomyopathy: results from protein A immunoadsorption.
Staudt A, Dörr M, Staudt Y, Böhm M, Probst M, Empen K, Plötz S, Maschke HE, Hummel A, Baumann G, Felix SB. Staudt A, et al. Am Heart J. 2005 Oct;150(4):729-36. doi: 10.1016/j.ahj.2004.11.002. Am Heart J. 2005. PMID: 16209975
BACKGROUND: Immunoadsorption (IA) by anti-immunoglobulin G (anti-IgG) columns that effectively eliminates total IgG, including IgG3 subclass, represents an additional therapeutic approach in dilated cardiomyopathy (DCM). A recent study revealed that IA with protein …
BACKGROUND: Immunoadsorption (IA) by anti-immunoglobulin G (anti-IgG) columns that effectively eliminates total IgG, including IgG3 subclass …
Validation of Noninvasive Measurement of Cardiac Output Using Inert Gas Rebreathing in a Cohort of Patients With Heart Failure and Reduced Ejection Fraction.
Hassan M, Wagdy K, Kharabish A, Selwanos PP, Nabil A, Elguindy A, ElFaramawy A, Elmahdy MF, Mahmoud H, Yacoub MH. Hassan M, et al. Circ Heart Fail. 2017 Mar;10(3):e003592. doi: 10.1161/CIRCHEARTFAILURE.116.003592. Circ Heart Fail. 2017. PMID: 28283502
METHODS AND RESULTS: The study included 97 patients with heart failure and reduced ejection fraction (age 4215.5 years; 64 patients (65.9%) had idiopathic dilated cardiomyopathy and 21 patients (21.6%) had ischemic heart disease). ...CONCLUSIONS: The IGR method is a …
METHODS AND RESULTS: The study included 97 patients with heart failure and reduced ejection fraction (age 4215.5 years; 64 patients (65.9%) …
Inhaled aerosolized iloprost in the evaluation of heart transplant candidates--experiences with 45 cases.
Sablotzki A, Hentschel T, Hofmann S, Simm A, Mühling J, Czeslick E. Sablotzki A, et al. J Clin Anesth. 2006 Mar;18(2):108-13. doi: 10.1016/j.jclinane.2005.08.018. J Clin Anesth. 2006. PMID: 16563327 Clinical Trial.
PURPOSE: Pulmonary hypertension represents a significant predictor of postoperative right heart insufficiency and increased mortality in patients undergoing orthotopic heart transplantation. As the use of intravenous vasodilators is limited by their systemic effects, we ev …
PURPOSE: Pulmonary hypertension represents a significant predictor of postoperative right heart insufficiency and increased mortality …